Nephrotoxicity Associated With Amphotericin B Deoxycholate in Neonates

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0b013e3181af6201PMID 19935267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antifungals in Systemic Neonatal Candidiasis

  2012cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Pediatric Antifungal Utilization: New Drugs, New Trends

  2008cited by this paper
• Changing Incidence of Candida Bloodstream Infections Among NICU Patients in the United States: 1995–2004

  2006cited by this paper
• Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.

  2006cited by this paper
• Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.

  2004cited by this paper
• Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity.

  2002cited by this paper
• Mortality and costs of acute renal failure associated with amphotericin B therapy.

  2001cited by this paper
• The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy.

  2001cited by this paper
• Review of 49 neonates with acquired fungal sepsis: further characterization.

  2001cited by this paper
• Candidal meningitis in neonates: a 10-year review.

  2000cited by this paper
• Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.

  1998cited by this paper
• Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis.

  1997cited by this paper
• Disseminated histoplasmosis in children: the role of itraconazole therapy.

  1996cited by this paper
• Neonatal Fungemia and Amphotericin B

  1993cited by this paper
• Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates

  1990cited by this paper
• Amphotericin B Nephrotoxicity

  1990cited by this paper
• Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.

  1990cited by this paper
• Amphotericin B nephrotoxicity.

  1988cited by this paper
• Consequences of candidemia for pediatric patients.

  1985cited by this paper
• Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).

  1984cited by this paper
• Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement.

  1984cited by this paper
• Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology.

  1984cited by this paper
• Systemic Candidiasis in Very Low-Birth-Weight Infants (<1,500 Grams)

  1984cited by this paper

• Irrational and Inappropriate Use of Antifungals in the NICU: A Narrative Review

  2026cites this paper
• Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects

  2025influential citation
• Addressing the silent threat: managing invasive Candida infections in hospitalized newborns

  2025cites this paper
• Antibiotics, Analgesic Sedatives, and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review

  2024cites this paper
• Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates

  2024cites this paper
• Infections fongiques en pédiatrie

  2023cites this paper
• Infecciones fúngicas en pediatría

  2023cites this paper
• Updated Perspectives on the Diagnosis and Management of Neonatal Invasive Candidiasis

  2023cites this paper
• Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review

  2023cites this paper
• Amphotericin B in Pediatrics: Analysis by Age Stratification Suggests a Greater Chance of Adverse Events from 13 Months of Age Onwards

  2022cites this paper
• Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity

  2021cites this paper
• Incidence of Acute Kidney Injury Among Infants in the Neonatal Intensive Care Unit Receiving Vancomycin With Either Piperacillin/Tazobactam or Cefepime.

  2020cites this paper
• Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population

  2020cites this paper
• Candida parapsilosis: from Genes to the Bedside

  2019cites this paper
• Escmid-ecmm guideline: diagnosis and management of invasive aspergillosis in neonates and children.

  2019cites this paper
• A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis

  2018cites this paper
• Adverse effects of amphotericin B deoxycholate in neonates of the National Hospital of Itauguá

  2018cites this paper
• Comprehensive drug utilization review in neonates: liposomal amphotericin B

  2018cites this paper
• Antifungal Drugs in Newborns and Children.

  2017cites this paper
• Infectious Diseases: Superficial Fungal Infections

  2017cites this paper
• Clinical pharmacology of antifungal agents in pediatrics: children are not small adults.

  2015cites this paper
• Therapeutic approach to Candida bezoar in children.

  2015cites this paper
• New antifungal and antiviral dosing.

  2015cites this paper
• Advances in the treatment of invasive neonatal candidiasis

  2015cites this paper
• Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants

  2014cites this paper
• Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting

  2014cites this paper
• [Invasive candidiasis in newborns: diagnosis, treatment and prophylaxis].

  2014cites this paper
• Acute kidney injury in neonatal age

  2014cites this paper
• Acute kidney injury in the neonate.

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants Jessica K. RobertsChris StockmannJonathan E. Constance • Justin StiersMichael G. SpigarelliRobert M. Ward •

  2014cites this paper
• Invasive aspergillosis in children and adolescents.

  2013cites this paper
• Newer antifungal agents

  2013cites this paper
• Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.

  2013cites this paper
• Clinical Features and Outcomes of Renal Mycetoma Complicated by Candida Sepsis in Newborn Infants

  2012cites this paper
• Antifungal Activity of the Essential Oils of Callitris neocaledonica and C. sulcata Heartwood (Cupressaceae)

  2012cites this paper
• The use of antifungal therapy in neonatal intensive care.

  2012cites this paper
• [Advantages and drawbacks of amphotericin formulations in children: literature review].

  2012cites this paper
• Ventajas y desventajas de los distintos tipos de anfotericina en pediatría: revisión de la bibliografía

  2012cites this paper
• Nephrotoxic Medication Exposure and Acute Kidney Injury in Neonates

  2012cites this paper
• Amphotericin B bladder irrigation for the treatment of neonatal bladder fungus ball

  2012cites this paper
• Ventajas y desventajas de los distintos tipos de anfotericina en pediatría: revisión de la bibliografía Advantages and drawbacks of amphotericin formulations in children: literature review

  2012cites this paper
• Is There Still a Place for Conventional Amphotericin B in the Treatment of Neonatal Fungal Infections?

  2012cites this paper
• Antifungal Therapy in Pediatric Patients

  2011cites this paper
• Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy – is there a ‘right’ choice?

  2011cites this paper
• Amphotericin B use in children: conventional and lipid-based formulations

  2011cites this paper
• Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy

  2010cites this paper
• Review Challenging issues in neonatal candidiasis

  2010cites this paper
• Update on antifungal agents for paediatric patients.

  2010cites this paper
• Challenging issues in neonatal candidiasis

  2010cites this paper